The DNA methylation inhibitor 5-azacytidine effectively reactivates the expression of these tumor suppressor genes, inhibits the growth of SPOP-mutated PCa cells both in vitro and in vivo, and enhances the anti-cancer efficacy of docetaxel 66. The gene discussed is SPOP; the disease is posterior cortical atrophy.